14-103562987-AG-AGG
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BS1_Supporting
The NM_001370595.2(COA8):c.-10dupG variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000037 in 1,540,980 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001370595.2 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COA8 | NM_001370595.2 | c.-10dupG | 5_prime_UTR_variant | Exon 1 of 5 | ENST00000409074.8 | NP_001357524.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COA8 | ENST00000409074 | c.-10dupG | 5_prime_UTR_variant | Exon 1 of 5 | 1 | NM_001370595.2 | ENSP00000386485.3 | |||
ENSG00000256500 | ENST00000472726 | c.-10dupG | 5_prime_UTR_variant | Exon 1 of 18 | 2 | ENSP00000439065.2 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152152Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000716 AC: 11AN: 153702Hom.: 0 AF XY: 0.0000585 AC XY: 5AN XY: 85456
GnomAD4 exome AF: 0.0000310 AC: 43AN: 1388712Hom.: 0 Cov.: 32 AF XY: 0.0000350 AC XY: 24AN XY: 686476
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152268Hom.: 0 Cov.: 34 AF XY: 0.0000671 AC XY: 5AN XY: 74468
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
This sequence change creates a premature translational stop signal (p.Arg11Alafs*57) in the APOPT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in APOPT1 are known to be pathogenic (PMID: 25175347). This variant is present in population databases (rs559856575, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with APOPT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1030024). For these reasons, this variant has been classified as Pathogenic. -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge -
Mitochondrial complex IV deficiency, nuclear type 1 Pathogenic:1
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
Mitochondrial complex 4 deficiency, nuclear type 17 Pathogenic:1
The variant has been reported to be associated with COA8 related disorder (ClinVar ID: VCV001030024). Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000072, PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
Inborn genetic diseases Uncertain:1
The c.30dupG (p.R11Afs*57) alteration, located in exon 1 (coding exon 1) of the APOPT1 gene, consists of a duplication of G at position 30, causing a translational frameshift with a predicted alternate stop codon after 57 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at